FDA Approved: SIMVASTATIN — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for Simvastatin submitted by Micro Labs Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

SUPPL AP for SIMVASTATIN (SIMVASTATIN)